MATCH Trademark

Trademark Overview


On Thursday, September 1, 2016, a trademark application was filed for MATCH with the United States Patent and Trademark Office. The USPTO has given the MATCH trademark a serial number of 87158936. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 6, 2018. This trademark is owned by Atara Biotherapeutics, Inc.. The MATCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Developing pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical trials of pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical research of the effectiveness of pharmaceutical and therapeutic preparations, namely, by conducting clinical trial on patients with EBV-Associated Post Transplant Lymphoproliferative Disease (EBV-PTLD)
match

General Information


Serial Number87158936
Word MarkMATCH
Filing DateThursday, September 1, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, August 6, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDeveloping pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical trials of pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical research of the effectiveness of pharmaceutical and therapeutic preparations, namely, by conducting clinical trial on patients with EBV-Associated Post Transplant Lymphoproliferative Disease (EBV-PTLD)

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 8, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAtara Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, August 6, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, August 6, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, January 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 8, 2018NON-FINAL ACTION E-MAILED
Monday, January 8, 2018NON-FINAL ACTION WRITTEN
Thursday, June 15, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 12, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 12, 2016LETTER OF SUSPENSION E-MAILED
Monday, December 12, 2016SUSPENSION LETTER WRITTEN
Saturday, December 10, 2016ASSIGNED TO EXAMINER
Thursday, September 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 5, 2016NEW APPLICATION ENTERED IN TRAM